Sphera Funds Management Ltd. Kiniksa Pharmaceuticals, Ltd. Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$10.7 - $15.79 $1.53 Million - $2.26 Million
143,000 Added 46.54%
450,283 $4.85 Million
Q4 2022

Feb 14, 2023
BUY
$11.42 - $17.05 $3.51 Million - $5.24 Million
307,283 New
307,283 $4.6 Million
Q4 2020

Feb 16, 2021
SELL
$14.8 - $21.15 $3.85 Million - $5.5 Million
-259,990 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$15.21 - $25.53 $3.95 Million - $6.64 Million
259,990 New
259,990 $3.98 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $690M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email